UHRF1 Overexpression Drives DNA Hypomethylation and Hepatocellular Carcinoma
Menée sur des poissons-zèbres, des lignées cellulaires et des échantillons tumoraux humains, cette étude met en évidence des mécanismes par lesquels, en induisant une hypométhylation de l'ADN, la surexpression du gène UHRF1 joue un rôle d'oncogène dans le carcinome hépatocellulaire
Ubiquitin-like with PHD and RING finger domains 1 (UHRF1) is an essential regulator of DNA methylation that is highly expressed in many cancers. Here, we use transgenic zebrafish, cultured cells, and human tumors to demonstrate that UHRF1 is an oncogene. UHRF1 overexpression in zebrafish hepatocytes destabilizes and delocalizes Dnmt1 and causes DNA hypomethylation and Tp53-mediated senescence. Hepatocellular carcinoma (HCC) emerges when senescence is bypassed. tp53 mutation both alleviates senescence and accelerates tumor onset. Human HCCs recapitulate this paradigm, as UHRF1 overexpression defines a subclass of aggressive HCCs characterized by genomic instability, TP53 mutation, and abrogation of the TP53-mediated senescence program. We propose that UHRF1 overexpression is a mechanism underlying DNA hypomethylation in cancer cells and that senescence is a primary means of restricting tumorigenesis due to epigenetic disruption. "UHRF1 overexpression induces DNA hypomethylation "Liver-specific overexpression of UHRF1 in zebrafish causes senescence and HCC "Human HCCs with high UHRF1 are aggressive and inactivate TP53-mediated senescence "Our studies in zebrafish and human tumors identify UHRF1 as an oncogene in HCC Mudbhary et al. show that overexpression of UHRF1, a critical DNA methylation regulator, in zebrafish causes DNA hypomethylation, p53-mediated senescence, and hepatocellular carcinoma (HCC) when senescence is bypassed. High UHRF1 expression in human HCC correlates with poor prognosis and TP53 mutation.